Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, Galenica (GALE.SW) has a market cap of $5.02 billion USD. According to our data, Galenica is ranked No.2536 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $5.02 B |
11.02%
|
| Dec 30, 2024 | $4.52 B |
5.39%
|
| Dec 29, 2023 | $4.29 B |
-0.96%
|
| Dec 30, 2022 | $4.33 B |
13.43%
|
| Dec 30, 2021 | $3.82 B |
19.54%
|
| Dec 30, 2020 | $3.19 B |
1.10%
|
| Dec 30, 2019 | $3.16 B |
43.05%
|
| Dec 28, 2018 | $2.21 B |
-10.85%
|
| Dec 29, 2017 | $2.48 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Roche
ROG.SW
|
$249.63 B |
38.060 B
|
Switzerland
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Bayer
BAYN.DE
|
$23.13 B |
0.001 M
|
Germany
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
 Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
Denmark
|
| Market Cap | = | GALE.SW Stock Price | * | GALE.SW Shares Outstanding |
| = | $100.75 | * | 49.83 M | |
| = | $5.02 B |